13F Filings/BAKER BROS. ADVISORS LP

BAKER BROS. ADVISORS LP

Hedge FundCIK0001263508LocationNEW YORK, NY 10014, United States

Long U.S. equity positions disclosed to the SEC on Form 13F-HR.

Latest filingQ2 2026Quarter ended30 Jun 2026Filed14 Aug 2026
Firm profile · Form ADV
SEC adviser registration

BAKER BROS. ADVISORS LP, established in January 2000, is an investment adviser that provides discretionary investment advisory services to private investment funds. The firm's investment strategy involves investing in public and private securities and related assets of life sciences and health care companies, as well as cash management investments. These investments can include equity securities, corporate debt, options, ETFs, money market funds, and royalties, with a focus on public securities but also including private companies and intellectual property.Summarised from the firm’s Form ADV Part 2A brochure.

CRD
158149 · 801-73446
Portfolio Turnover
3%
Of book traded, QoQ
Positions
84
Long U.S. equities
Top 10 Concentration
73%
Of reported value
QoQ Change
$2.5B
Value change
Assets under management
Form ADV RAUM · client mix · 13F over time
Regulatory AUM
$28.1B
Form ADV, as of Mar 2026
100% discretionary ($28.1B)
By client type
Pooled investment vehicles: $28.1B (100.0%) · 2 clients
Pooled investment vehicles
$28.1B · 100%
13F AUM over time
$20.0B
Q2 ’26 · 13F AUM
110%
42 quarters
Reported Holdings
Q2 2026 · upgrade to Pro for past quarters
★ Position spotlightINCYIncyte Corporation · 17.5% of bookThis highlighted stock and its 1Y chart are public
Loading position history…
SecuritySharesMarket ValueEst. CostLast PxEst. Return% PortfolioΔ SharesAction
Incyte Corporation
INCY· Health Care
30.76MSH$3.5B~$113.36$126.7511.8%17.5% 0.1%Added
BeOne Medicines Ltd.
ONC· Health Care
8.80MSH$2.5B~$284.97$358.2625.7%12.6% 0.0%Added
Revolution Medicines, Inc.
RVMD· Health Care
11.44MSH$2.1B~$187.28$210.0212.1%10.7% 19.8%Added
Madrigal Pharmaceuticals, Inc.
MDGL· Health Care
2.14MSH$1.2B~$536.95$541.080.8%5.8% 0.1%Added
ACADIA Pharmaceuticals Inc.
ACAD· Health Care
42.91MSH$1.1B~$25.30$28.0210.8%5.4% 0.0%Added
Kymera Therapeutics, Inc.
KYMR· Health Care
8.66MSH$992.7M~$114.67$117.392.4%5.0%Unchanged
Insmed Incorporated
INSM· Health Care
8.80MSH$937.8M~$106.62$126.2918.4%4.7% 18.5%Added
Celcuity Inc.
CELC· Health Care
7.92MSH$828.2M~$104.62$95.708.5%4.2%Unchanged
Kodiak Sciences Inc.
KOD· Health Care
19.92MSH$776.1M~$38.96$35.369.2%3.9%Unchanged
Rhythm Pharmaceuticals, Inc.
RYTM· Health Care
5.60MSH$622.3M~$111.03$102.747.5%3.1%Unchanged
INCYIncyte CorporationAdded
$3.5B· 17.5%· 30.76M SH· 0.1%· cost $113.36· last $126.75· 11.8%
Health Care · COM · SOLE
ONCBeOne Medicines Ltd.Added
$2.5B· 12.6%· 8.80M SH· 0.0%· cost $284.97· last $358.26· 25.7%
Health Care · SPONSORED ADS · SOLE
RVMDRevolution Medicines, Inc.Added
$2.1B· 10.7%· 11.44M SH· 19.8%· cost $187.28· last $210.02· 12.1%
Health Care · COM · SOLE
MDGLMadrigal Pharmaceuticals, Inc.Added
$1.2B· 5.8%· 2.14M SH· 0.1%· cost $536.95· last $541.08· 0.8%
Health Care · COM · SOLE
ACADACADIA Pharmaceuticals Inc.Added
$1.1B· 5.4%· 42.91M SH· 0.0%· cost $25.30· last $28.02· 10.8%
Health Care · COM · SOLE
KYMRKymera Therapeutics, Inc.Unchanged
$992.7M· 5.0%· 8.66M SH· · cost $114.67· last $117.39· 2.4%
Health Care · COM · SOLE
INSMInsmed IncorporatedAdded
$937.8M· 4.7%· 8.80M SH· 18.5%· cost $106.62· last $126.29· 18.4%
Health Care · COM PAR $.01 · SOLE
CELCCelcuity Inc.Unchanged
$828.2M· 4.2%· 7.92M SH· · cost $104.62· last $95.70· 8.5%
Health Care · COM · SOLE
KODKodiak Sciences Inc.Unchanged
$776.1M· 3.9%· 19.92M SH· · cost $38.96· last $35.36· 9.2%
Health Care · COM · SOLE
RYTMRhythm Pharmaceuticals, Inc.Unchanged
$622.3M· 3.1%· 5.60M SH· · cost $111.03· last $102.74· 7.5%
Health Care · COM · SOLE
110 of 84
1 / 9
Sector Breakdown
Q2 2026
Health Care94.2% · $18.8B
Unclassified5.8% · $1.2B